ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB)

50 filings reported holding ENZB - ENZO BIOCHEM INC - Common Stock, par value $0.01 per share as of Q4 2024.
ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 13.6M shares of 52.3M outstanding shares and own 26.02% of the company stock.
Largest 10 shareholders include HARBERT FUND ADVISORS, INC. (5.18M shares), RENAISSANCE TECHNOLOGIES LLC (2.37M shares), VANGUARD GROUP INC (1.86M shares), BlackRock, Inc. (960K shares), Mink Brook Asset Management LLC (808K shares), GEODE CAPITAL MANAGEMENT, LLC (367K shares), DIMENSIONAL FUND ADVISORS LP (296K shares), RBF Capital, LLC (250K shares), WITTENBERG INVESTMENT MANAGEMENT, INC. (188K shares), and BRIDGEWAY CAPITAL MANAGEMENT, LLC (177K shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.